Developing, fabrication and functionalization of soy bioactive peptides-nano particles therapeutic nano composites: A review

IF 5.2 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Khalid Amin , Jiaxin Li , Bo Lyu , Sainan Wang , Hongling Fu , Bin Liu , Hansong Yu
{"title":"Developing, fabrication and functionalization of soy bioactive peptides-nano particles therapeutic nano composites: A review","authors":"Khalid Amin ,&nbsp;Jiaxin Li ,&nbsp;Bo Lyu ,&nbsp;Sainan Wang ,&nbsp;Hongling Fu ,&nbsp;Bin Liu ,&nbsp;Hansong Yu","doi":"10.1016/j.ijpharm.2025.125983","DOIUrl":null,"url":null,"abstract":"<div><div>Nanoparticles (NPs) therapeutics has emerged as advanced systems for personalized therapeutics. However, they encounter several obstacles in attaining exact specificity and sensitivity for disease therapies. Therefore, the development of NPs with novel approaches is critically important to improve their therapeutic efficacy. One intellectual approach is assembling and compositing them with active biomaterials like smart disease targeting peptides. Bioactive peptides derived from soybeans, are reported to involve in several physiological functions like reducing chronic diseases such as cancer, cardiovascular disease (CVD) obesity, insulin-resistance/type II diabetes, immune disorders and inflammatory diseases. Therefore, the conjugation of soy bioactive peptides with nanoparticles is a promising strategy towards engineered therapeutic nano systems. However, these conjugates of soy peptides-nanoparticles composites (SPNCs) are highly under considered. Engineered nanoparticles with peptides, captured attention as innovative therapeutic platforms. Consequently, SPNCs engineered nanostructure, have the high potential for future therapeutics as their composite/hybrid features of therapeutic NPs and soy bioactive peptides, can not only enhance their therapeutic behaviors but also can resolve their challenges they face as an individual. In this review for the first time, multimodal SPNCs with acclaimed therapeutic abilities are discussed which set a foundational understanding for the future nanotherapeutics. The foundational details of soy peptides, NPs and their chemistries and corresponding interactions with disease modes are discussed. Finally, precise guidelines for accuracy techniques to engineer SPNCs with efficient therapeutic abilities are explored. This study established the groundwork for advancement of composite soy bioactive peptides with NPs to achieve therapeutic SPNCs with high target specific abilities.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"682 ","pages":"Article 125983"},"PeriodicalIF":5.2000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378517325008208","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Nanoparticles (NPs) therapeutics has emerged as advanced systems for personalized therapeutics. However, they encounter several obstacles in attaining exact specificity and sensitivity for disease therapies. Therefore, the development of NPs with novel approaches is critically important to improve their therapeutic efficacy. One intellectual approach is assembling and compositing them with active biomaterials like smart disease targeting peptides. Bioactive peptides derived from soybeans, are reported to involve in several physiological functions like reducing chronic diseases such as cancer, cardiovascular disease (CVD) obesity, insulin-resistance/type II diabetes, immune disorders and inflammatory diseases. Therefore, the conjugation of soy bioactive peptides with nanoparticles is a promising strategy towards engineered therapeutic nano systems. However, these conjugates of soy peptides-nanoparticles composites (SPNCs) are highly under considered. Engineered nanoparticles with peptides, captured attention as innovative therapeutic platforms. Consequently, SPNCs engineered nanostructure, have the high potential for future therapeutics as their composite/hybrid features of therapeutic NPs and soy bioactive peptides, can not only enhance their therapeutic behaviors but also can resolve their challenges they face as an individual. In this review for the first time, multimodal SPNCs with acclaimed therapeutic abilities are discussed which set a foundational understanding for the future nanotherapeutics. The foundational details of soy peptides, NPs and their chemistries and corresponding interactions with disease modes are discussed. Finally, precise guidelines for accuracy techniques to engineer SPNCs with efficient therapeutic abilities are explored. This study established the groundwork for advancement of composite soy bioactive peptides with NPs to achieve therapeutic SPNCs with high target specific abilities.

Abstract Image

大豆生物活性肽-纳米颗粒治疗性纳米复合材料的开发、制备及功能化研究进展。
纳米粒子(NPs)治疗已成为个性化治疗的先进系统。然而,他们在获得疾病治疗的精确特异性和敏感性方面遇到了一些障碍。因此,利用新方法开发NPs对于提高其治疗效果至关重要。一种聪明的方法是将它们与活性生物材料(如智能疾病靶向肽)组装和合成。据报道,从大豆中提取的生物活性肽涉及多种生理功能,如减少癌症、心血管疾病(CVD)肥胖、胰岛素抵抗/ II型糖尿病、免疫紊乱和炎症性疾病等慢性疾病。大豆生物活性肽与纳米颗粒的结合是一种很有前途的工程治疗纳米系统策略。然而,这些大豆肽-纳米颗粒复合物(SPNCs)的共轭物被高度重视。工程纳米颗粒与肽,引起了人们的关注,作为创新的治疗平台。因此,SPNCs工程纳米结构,由于其治疗性NPs和大豆生物活性肽的复合/杂交特征,在未来的治疗中具有很大的潜力,不仅可以增强其治疗行为,而且可以解决它们作为个体面临的挑战。在这篇综述中,我们首次讨论了具有广泛治疗能力的多模态spnc,为未来的纳米治疗奠定了基础。本文讨论了大豆多肽、NPs及其化学成分的基本细节以及与疾病模式的相应相互作用。最后,探讨了精确技术的精确指南,以设计具有有效治疗能力的spnc。本研究为利用NPs复合大豆生物活性肽获得具有高靶向特异性的治疗性spnc奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.70
自引率
8.60%
发文量
951
审稿时长
72 days
期刊介绍: The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信